After hanging out the for sale sign and filing for bankruptcy ear | According to Invitae the transaction covers ...

A $4.9 billion hole has appeared in Gilead’s pipeline. After years of setbacks, the big biotech dealt a final blow to its ...

Medtronic has secured FDA approval for its first closed-loop spinal cord stimulator, designed to take in signals from the ...

One of Chris Boerner’s first tours as the new CEO of Bristol Myers Squibb was of a 256,000 square-foot research facility in ...

Bristol Myers Squibb is the latest large pharma to wield the restructuring ax, with plans to cut $1.5 billion in costs by the ...

Last year was a difficult one for ex-Stanford president Marc Tessier-Lavigne, Ph.D. An investigation into his prior research ...

In recent years, artificial intelligence programs for drug design have steadily shown they can help explore far beyond just ...

Parexel has struck a multi-year deal with Palantir Technologies to integrate its artificial intelligence systems into Parexel ...

The handheld ultrasound developer Exo has launched two new FDA-cleared artificial intelligence applications tied to its ...

As a whole, Boston Scientific reported a 13.8% increase in quarterly revenue, for $3.86 billion in net sales. That outpaced ...

After BioMarin’s new leadership conducted a “strategic R&D asset review,” three of its “most productive” assets are being ...

If you asked an AI to generate a brand-new drug discovery biotech with a team of some of the biggest names in the biz for you ...